Novartis AG v. Noven Pharms., Inc.
Novartis AG v. Noven Pharms., Inc., 2016-1678
In an appeal of inter partes review of pharmaceutical patents, the Patent Trial and Appeal Board’s findings that various claims of the Patents-in-Suit would have been obvious over the prior art, is affirmed where: 1) prior judicial opinions did not bind the PTAB; and 2) substantial evidence supports the PTAB’s underlying factual findings that the asserted claims would have been unpatentable as obvious.
- Published 2017/04/04
- United States Federal Circuit